Mixed Mycobacterium kansasii and Mycobacterium smegmatis infection in an adult‐onset immunodeficiency patient with anti‐interferon‐γ autoantibodies

Abstract Anti‐interferon‐gamma autoantibody (AIGA) is a rare adult‐onset immunodeficiency disease that increases the risk of occult infection. Nontuberculous mycobacteria (NTM) infections represent a diverse group of species and subspecies, and mixed infections with two or more NTM species have been...

Full description

Bibliographic Details
Main Authors: Yun‐Tse Chou, Wei‐An Liao, Chin‐Wei Kuo
Format: Article
Language:English
Published: Wiley 2023-07-01
Series:Respirology Case Reports
Subjects:
Online Access:https://doi.org/10.1002/rcr2.1178
_version_ 1797777277708140544
author Yun‐Tse Chou
Wei‐An Liao
Chin‐Wei Kuo
author_facet Yun‐Tse Chou
Wei‐An Liao
Chin‐Wei Kuo
author_sort Yun‐Tse Chou
collection DOAJ
description Abstract Anti‐interferon‐gamma autoantibody (AIGA) is a rare adult‐onset immunodeficiency disease that increases the risk of occult infection. Nontuberculous mycobacteria (NTM) infections represent a diverse group of species and subspecies, and mixed infections with two or more NTM species have been reported. However, there is no consensus on the optimal antibiotics or immune modulator treatments for mixed NTM infections in AIGA patients. Here, we present the case of a 40‐year‐old female who initially presented with suspected lung cancer with obstructive pneumonitis. Tissue samples obtained through bronchoscopy, endoscopy, and bone marrow biopsy revealed disseminated mycobacterium infection. PCR‐based testing confirmed a mixed pulmonary infection with Mycobacterium kansasii and Mycobacterium smegmatis, as well as M. kansasii bacteremia. The patient received 12 months of anti‐NTM medications for M. kansasii, and the symptoms improved. Additionally, the images showed resolution after 6 months, even without the need for immune modulator treatment.
first_indexed 2024-03-12T23:01:51Z
format Article
id doaj.art-82d3e16f6e6244cfb905a66f32a82ed0
institution Directory Open Access Journal
issn 2051-3380
language English
last_indexed 2024-03-12T23:01:51Z
publishDate 2023-07-01
publisher Wiley
record_format Article
series Respirology Case Reports
spelling doaj.art-82d3e16f6e6244cfb905a66f32a82ed02023-07-19T10:41:33ZengWileyRespirology Case Reports2051-33802023-07-01117n/an/a10.1002/rcr2.1178Mixed Mycobacterium kansasii and Mycobacterium smegmatis infection in an adult‐onset immunodeficiency patient with anti‐interferon‐γ autoantibodiesYun‐Tse Chou0Wei‐An Liao1Chin‐Wei Kuo2Department of Internal Medicine National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University Tainan TaiwanDepartment of Pathology National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University Tainan TaiwanDepartment of Internal Medicine National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University Tainan TaiwanAbstract Anti‐interferon‐gamma autoantibody (AIGA) is a rare adult‐onset immunodeficiency disease that increases the risk of occult infection. Nontuberculous mycobacteria (NTM) infections represent a diverse group of species and subspecies, and mixed infections with two or more NTM species have been reported. However, there is no consensus on the optimal antibiotics or immune modulator treatments for mixed NTM infections in AIGA patients. Here, we present the case of a 40‐year‐old female who initially presented with suspected lung cancer with obstructive pneumonitis. Tissue samples obtained through bronchoscopy, endoscopy, and bone marrow biopsy revealed disseminated mycobacterium infection. PCR‐based testing confirmed a mixed pulmonary infection with Mycobacterium kansasii and Mycobacterium smegmatis, as well as M. kansasii bacteremia. The patient received 12 months of anti‐NTM medications for M. kansasii, and the symptoms improved. Additionally, the images showed resolution after 6 months, even without the need for immune modulator treatment.https://doi.org/10.1002/rcr2.1178adult‐onset immunodeficiencyanti‐interferon‐γ autoantibodiesinterferon‐γ deficiencymycobacteria infection
spellingShingle Yun‐Tse Chou
Wei‐An Liao
Chin‐Wei Kuo
Mixed Mycobacterium kansasii and Mycobacterium smegmatis infection in an adult‐onset immunodeficiency patient with anti‐interferon‐γ autoantibodies
Respirology Case Reports
adult‐onset immunodeficiency
anti‐interferon‐γ autoantibodies
interferon‐γ deficiency
mycobacteria infection
title Mixed Mycobacterium kansasii and Mycobacterium smegmatis infection in an adult‐onset immunodeficiency patient with anti‐interferon‐γ autoantibodies
title_full Mixed Mycobacterium kansasii and Mycobacterium smegmatis infection in an adult‐onset immunodeficiency patient with anti‐interferon‐γ autoantibodies
title_fullStr Mixed Mycobacterium kansasii and Mycobacterium smegmatis infection in an adult‐onset immunodeficiency patient with anti‐interferon‐γ autoantibodies
title_full_unstemmed Mixed Mycobacterium kansasii and Mycobacterium smegmatis infection in an adult‐onset immunodeficiency patient with anti‐interferon‐γ autoantibodies
title_short Mixed Mycobacterium kansasii and Mycobacterium smegmatis infection in an adult‐onset immunodeficiency patient with anti‐interferon‐γ autoantibodies
title_sort mixed mycobacterium kansasii and mycobacterium smegmatis infection in an adult onset immunodeficiency patient with anti interferon γ autoantibodies
topic adult‐onset immunodeficiency
anti‐interferon‐γ autoantibodies
interferon‐γ deficiency
mycobacteria infection
url https://doi.org/10.1002/rcr2.1178
work_keys_str_mv AT yuntsechou mixedmycobacteriumkansasiiandmycobacteriumsmegmatisinfectioninanadultonsetimmunodeficiencypatientwithantiinterferongautoantibodies
AT weianliao mixedmycobacteriumkansasiiandmycobacteriumsmegmatisinfectioninanadultonsetimmunodeficiencypatientwithantiinterferongautoantibodies
AT chinweikuo mixedmycobacteriumkansasiiandmycobacteriumsmegmatisinfectioninanadultonsetimmunodeficiencypatientwithantiinterferongautoantibodies